Kidney Health for Everyone Everywhere - from Prevention to Detection and Equitable Access to Care

被引:1
作者
Li, Philip Kam-Tao [1 ]
Garcia-Garcia, Guillermo [2 ]
Lui, Siu-Fai [3 ]
Andreoli, Sharon [4 ]
Fung, Winston Wing-Shing [1 ]
Hradsky, Anne [5 ]
Kumaraswami, Latha [6 ]
Liakopoulos, Vassilios [7 ]
Rakhimova, Ziyoda [5 ]
Saadi, Gamal [8 ]
Strani, Luisa [5 ]
Ulasi, Ifeoma [9 ]
Kalantar-Zadeh, Kamyar [10 ]
机构
[1] Chinese Univ Hong Kong, Dept Med & Therapeut, Carol & Richard Yu PD Res Ctr, Prince Wales Hosp, Hong Kong, Peoples R China
[2] Univ Guadalajara, Nephrol Serv, Hosp Civil Guadalajara Fray Antonio Alcalde, Hlth Sci Ctr, Guadalajara, Jalisco, Mexico
[3] Chinese Univ Hong Kong, Div Hlth Syst Policy & Management, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China
[4] Indiana Univ Sch Med, James Whitcomb Riley Hosp Children, Indianapolis, IN 46202 USA
[5] World Kidney Day Off, Brussels, Belgium
[6] Tanker Fdn, Chennai, Tamil Nadu, India
[7] Aristotle Univ Thessaloniki, Div Nephrol & Hypertens, Dept Internal Med 1, AHEPA Hosp, Thessaloniki, Greece
[8] Cairo Univ, Nephrol Unit, Dept Internal Med, Fac Med, Giza, Egypt
[9] Univ Nigeria, Renal Unit, Dept Med, Coll Med, Ituku Ozalla, Enugu, Nigeria
[10] Univ Calif Irvine, Div Nephrol & Hypertens & Kidney Transplantat, Sch Med, Orange, CA 92668 USA
关键词
CARDIOVASCULAR RISK; POSITION STATEMENT; COST-EFFECTIVENESS; DISEASE; CKD; MANAGEMENT; STRATEGIES; COUNTRIES;
D O I
10.4103/1319-2442.284004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The global burden of chronic kidney disease (CKD) is rapidly increasing with a projection of becoming the 5th most common cause of years of life lost globally by 2040. Aggravatingly, CKD is a major cause of catastrophic health expenditure. The costs of dialysis and transplantation consume up to 3% of the annual healthcare budget in high-income countries. Crucially, however, the onset and progression of CKD is often preventable. In 2020, the World Kidney Day campaign highlights the importance of preventive interventions - be it primary, secondary or tertiary. This complementing article focuses on outlining and analyzing measures prevention, including blood pressure optimization and glycemic control, should be the main goal of education and clinical interventions. In patients with advanced CKD, management of co-morbidities such as uremia and cardiovascular disease is a highly recommended preventative intervention to avoid or delay dialysis or kidney transplantation. Political efforts are needed to proliferate the preventive approach. While national policies and strategies for non-communicable diseases might be present in a country, specific policies directed toward education and awareness about CKD screening, management and treatment are often lacking. Hence, there is an urgent need to increase the awareness of the importance of preventive measures throughout populations, professionals and policy makers.
引用
收藏
页码:298 / 311
页数:14
相关论文
共 57 条
[41]   Does AKI Truly Lead to CKD? [J].
Rifkin, Dena E. ;
Coca, Steven G. ;
Kalantar-Zade, Kamyar .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (06) :979-984
[42]   The Primary Care Perspective on Routine Urine Dipstick Screening to Identify Patients with Albuminuria [J].
Samal, Lipika ;
Linder, Jeffrey A. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (01) :131-135
[43]  
Saran Rajiv, 2019, Am J Kidney Dis, V73, pA7, DOI 10.1053/j.ajkd.2019.01.001
[44]   Web-based Kidney Education: Supporting Patient Self-Management [J].
Schatell, Dori .
SEMINARS IN DIALYSIS, 2013, 26 (02) :154-158
[45]   The global nephrology workforce: emerging threats and potential solutions! [J].
Sharif, Muhammad U. ;
Elsayed, Mohamed E. ;
Stack, Austin G. .
CLINICAL KIDNEY JOURNAL, 2016, 9 (01) :11-22
[46]   Chronic kidney disease care models in low- and middle-income countries: a systematic review [J].
Stanifer, John W. ;
Von Isenburg, Megan ;
Chertow, Glenn M. ;
Anand, Shuchi .
BMJ GLOBAL HEALTH, 2018, 3 (02)
[47]   Current Management of Patients With Acquired Solitary Kidney [J].
Tantisattamo, Ekamol ;
Dafoe, Donald C. ;
Reddy, Uttam G. ;
Ichii, Hirohito ;
Rhee, Connie M. ;
Streja, Elani ;
Landman, Jaime ;
Kalantar-Zadeh, Kamyar .
KIDNEY INTERNATIONAL REPORTS, 2019, 4 (09) :1205-1218
[48]  
Tapia-Conyer R, 2017, CHRONIC KIDNEY DISEASE IN DISADVANTAGED POPULATIONS, P337, DOI 10.1016/B978-0-12-804311-0.00032-7
[49]   Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study [J].
Tonelli, Marcello ;
Muntner, Paul ;
Lloyd, Anita ;
Manns, Braden J. ;
Klarenbach, Scott ;
Pannu, Neesh ;
James, Matthew T. ;
Hemmelgarn, Brenda R. .
LANCET, 2012, 380 (9844) :807-814
[50]   Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease [J].
Torres, Vicente E. ;
Chapman, Arlene B. ;
Devuyst, Olivier ;
Gansevoort, Ron T. ;
Grantham, Jared J. ;
Higashihara, Eiji ;
Perrone, Ronald D. ;
Krasa, Holly B. ;
Ouyang, John ;
Czerwiec, Frank S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25) :2407-2418